Join us on our journey as we transform the landscape of therapeutics. Together, we can create life-saving solutions. Welcome to Extrave Bioscience, where science meets purpose, and miracles happen every day.
Our Focus
At Extrave Bioscience, we're not just redefining medicine; we're revolutionizing it. Our mission is simple yet profound: to harness the power of the most remarkable microcarriers, extracellular vesicles, and transform them into life-saving medicines that touch lives and change futures.
Innovation at Our Core
Our team combines cutting-edge science, technology, and a deep commitment to improving human health. We're breaking down barriers and forging new paths in the field of therapeutics, with a focus on creating solutions for some of the world's most challenging diseases.
Science With a Purpose
Our work isn't just about the science; it's about the lives we touch. Extrave Bioscience is unwavering in its dedication to creating life-saving therapies that offer new hope, new possibilities, and new beginnings. We're not just a company; we're a catalyst for change.
Global Impact,
Local Commitment
Our reach extends worldwide, but our commitment to patients remains personal. We understand that every life is unique, and our medicines are tailored to reflect that. Extrave Bioscience is dedicated to making a meaningful impact, one patient at a time.
Engineered for Healing
We believe in the incredible potential of natural extracellular vesicles. These are tiny bubbles secreted by cells, and we've unlocked their potential to carry a message of hope and healing. Our cutting-edge research and innovation have allowed us to harness these vesicles, turning them into precision therapeutics that can target diseases at their root.
Pioneers since 2018
Extrave Bioscience is not just a newcomer; we've been a part of the EV therapeutic landscape since 2018. This early entry has allowed us to secure some of the earliest patents, solidifying our position as leaders in the field.
Seizing the Neuromuscular Revolution
Discover the unmet medical need, our pioneering nanotechnology, and the transformative potential of Extrave Bioscience in treating catastrophic neuromuscular disorders.
Leading the Way in Neuromuscular Therapies
Meet the visionaries behind Extrave Bioscience with a profound expertise in extracellular vesicle biology, poised to redefine the future of neuromuscular disorder treatments.
Unlocking Hope: Our Breakthrough in Neuromuscular Disorder Treatment
Explore our groundbreaking technology designed to tackle the challenges in treating genetic muscle disorders, offering a lifeline to patients and transforming the landscape of gene therapy.
Revolutionizing DMD Treatment: A Global Mission
Learn how our proprietary technology is poised to save lives, enhance existing therapies, and seize a significant share of the $4.11 billion global DMD drug market.
The Future of Gene Therapy is Here
Discover how Extrave Bioscience's cutting-edge platform transcends the limitations of current gene therapies, promising efficient vector production, potency, and accessibility for all patients.
Saving Lives, One Breakthrough at a Time
Witness how our novel approach leverages natural cellular processes to create a more efficient drug delivery system, offering hope to patients previously deemed untreatable.
What Sets Us Apart
Platform Technology
Extrave Bioscience boasts a versatile 'platform' technology that can effectively deliver a wide range of therapeutics, making it adaptable and multifunctional.
Milestone Achievement
We proudly became the first to deliver full-size dystrophin RNA and protein for the treatment of DMD, marking a significant breakthrough in the field.
Efficient EV Production
Our streamlined production process involves fewer steps, leading to cost savings, simplified scaling, and faster production of EVs.
Precise Skeletal Muscle Targeting
Extrave Bioscience has demonstrated its capability to specifically target skeletal muscles. This precision ensures that therapeutic drugs for muscle disorders reach their intended destination.
Enhancing Existing AAV Therapeutics
Our technology enables us to incorporate existing Adeno-Associated Viruses (AAVs) inside EVs, addressing major challenges associated with AAV treatments. This includes the potential for repeat dosages, reduced off-target effects, and greater applicability to a wide range of patient populations.
Sustainability
We take pride in our eco-friendly approach. Extrave Bioscience can create therapeutic compounds from what many AAV companies discard as "waste" during their production process, minimizing waste and maximizing resources.